Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Hatherill

Showing results (111-120 of 222) with videos related to

Pageof 23
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Development of a Rapid Automated Point-of-Care Test for <i>Mycobacterium tuberculosis</i> Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR SystemMatthew A Butzler, Jennifer L Reed, Alaina M Olson, et al.
The Lancet. Respiratory Medicine|February 21, 2017
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort studyJason R Andrews, Elisa Nemes, Michele Tameris, et al.
BMC Infectious Diseases|June 11, 2014
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell responseMagali Matsumiya, Stephanie A Harris, Iman Satti, et al.
Ebiomedicine|February 20, 2022
The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis riskHumphrey Mulenga, Andrew Fiore-Gartland, Simon C Mendelsohn, et al.
Frontiers in Medicine|March 17, 2022
Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary TuberculosisIsmaheel O Lawal, Kgomotso M G Mokoala, Matsontso Mathebula, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
Diagnostic performance of an optimized transcriptomic signature of risk of tuberculosis in cryopreserved peripheral blood mononuclear cellsFatoumatta Darboe, Stanley Kimbung Mbandi, Ethan G Thompson, et al.
Lancet (London, England)|February 9, 2013
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialMichele D Tameris, Mark Hatherill, Bernard S Landry, et al.
Plos Medicine|February 12, 2026
Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling studyHira Tanvir, Rebecca A Clark, Tom Sumner, et al.
Journal of Clinical Microbiology|December 14, 2018
Noninvasive Detection of Tuberculosis by Oral Swab AnalysisAngelique K Luabeya, Rachel C Wood, Justin Shenje, et al.
Nature Communications|November 4, 2022
Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infantsIman Satti, Rachel E Wittenberg, Shuailin Li, et al.
Pageof 23

Showing results (111-120 of 222) with videos related to

Sort By:
Pageof 23
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Development of a Rapid Automated Point-of-Care Test for <i>Mycobacterium tuberculosis</i> Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR SystemMatthew A Butzler, Jennifer L Reed, Alaina M Olson, et al.
The Lancet. Respiratory Medicine|February 21, 2017
Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort studyJason R Andrews, Elisa Nemes, Michele Tameris, et al.
BMC Infectious Diseases|June 11, 2014
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell responseMagali Matsumiya, Stephanie A Harris, Iman Satti, et al.
Ebiomedicine|February 20, 2022
The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis riskHumphrey Mulenga, Andrew Fiore-Gartland, Simon C Mendelsohn, et al.
Frontiers in Medicine|March 17, 2022
Correlation Between CT Features of Active Tuberculosis and Residual Metabolic Activity on End-of-Treatment FDG PET/CT in Patients Treated for Pulmonary TuberculosisIsmaheel O Lawal, Kgomotso M G Mokoala, Matsontso Mathebula, et al.
Tuberculosis (Edinburgh, Scotland)|March 11, 2018
Diagnostic performance of an optimized transcriptomic signature of risk of tuberculosis in cryopreserved peripheral blood mononuclear cellsFatoumatta Darboe, Stanley Kimbung Mbandi, Ethan G Thompson, et al.
Lancet (London, England)|February 9, 2013
Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trialMichele D Tameris, Mark Hatherill, Bernard S Landry, et al.
Plos Medicine|February 12, 2026
Estimating the population impact of new tuberculosis vaccines depending on efficacy against infectious asymptomatic tuberculosis: A modelling studyHira Tanvir, Rebecca A Clark, Tom Sumner, et al.
Journal of Clinical Microbiology|December 14, 2018
Noninvasive Detection of Tuberculosis by Oral Swab AnalysisAngelique K Luabeya, Rachel C Wood, Justin Shenje, et al.
Nature Communications|November 4, 2022
Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infantsIman Satti, Rachel E Wittenberg, Shuailin Li, et al.
Pageof 23